These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24752144)

  • 21. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
    Sain NM; Liang A; Kane SA; Urban MO
    Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilocarpine-induced seizures in rodents--17 years on.
    Turski WA
    Pol J Pharmacol; 2000; 52(1):63-5. PubMed ID: 10949124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium.
    Williams MB; Jope RS
    Psychopharmacology (Berl); 1995 Dec; 122(4):363-8. PubMed ID: 8657834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor.
    Schulte K; Steingrüber N; Jergas B; Redmer A; Kurz CM; Buchalla R; Lutz B; Zimmer A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):385-96. PubMed ID: 22215206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptor 1/2 double-knockout mice develop epilepsy.
    Rowley S; Sun X; Lima IV; Tavenier A; de Oliveira ACP; Dey SK; Danzer SC
    Epilepsia; 2017 Dec; 58(12):e162-e166. PubMed ID: 29105060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration.
    Pisanti S; Picardi P; Pallottini V; Martini C; Petrosino S; Proto MC; Vitale M; Laezza C; Gazzerro P; Di Marzo V; Bifulco M
    J Cell Physiol; 2015 Dec; 230(12):2905-14. PubMed ID: 25684344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Des-acyl ghrelin attenuates pilocarpine-induced limbic seizures via the ghrelin receptor and not the orexin pathway.
    Portelli J; Coppens J; Demuyser T; Smolders I
    Neuropeptides; 2015 Jun; 51():1-7. PubMed ID: 26002375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway.
    Lima IVA; Bellozi PMQ; Batista EM; Vilela LR; Brandão IL; Ribeiro FM; Moraes MFD; Moreira FA; de Oliveira ACP
    Neuropharmacology; 2020 Oct; 176():108156. PubMed ID: 32574650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
    de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
    Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.
    Svensson AC; Johansson M; Persson E; Carchenilla MS; Jacobsson SO
    J Neurosci Res; 2006 May; 83(6):1128-40. PubMed ID: 16477621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.
    Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
    Neuroscience; 2015 Sep; 303():149-59. PubMed ID: 26135674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
    Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
    J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of vesicular zinc and appearance of perikaryal zinc after seizures induced by pilocarpine.
    Suh SW; Thompson RB; Frederickson CJ
    Neuroreport; 2001 May; 12(7):1523-5. PubMed ID: 11388441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
    Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice.
    Breivogel CS; Vaghela MS
    J Recept Signal Transduct Res; 2015 Feb; 35(1):98-106. PubMed ID: 25779032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors.
    Aghaei I; Rostampour M; Shabani M; Naderi N; Motamedi F; Babaei P; Khakpour-Taleghani B
    Epilepsy Res; 2015 Nov; 117():23-8. PubMed ID: 26370914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilocarpine-induced convulsions in rats: evidence for muscarinic receptor-mediated activation of locus coeruleus and norepinephrine release in cholinolytic seizure development.
    el-Etri MM; Ennis M; Jiang M; Shipley MT
    Exp Neurol; 1993 May; 121(1):24-39. PubMed ID: 7684335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
    Gamage TF; Ignatowska-Jankowska BM; Wiley JL; Abdelrahman M; Trembleau L; Greig IR; Thakur GA; Tichkule R; Poklis J; Ross RA; Pertwee RG; Lichtman AH
    Behav Pharmacol; 2014 Apr; 25(2):182-5. PubMed ID: 24603340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
    Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
    Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glyoxalase 1 and its substrate methylglyoxal are novel regulators of seizure susceptibility.
    Distler MG; Gorfinkle N; Papale LA; Wuenschell GE; Termini J; Escayg A; Winawer MR; Palmer AA
    Epilepsia; 2013 Apr; 54(4):649-57. PubMed ID: 23409935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.